Brief: Cleo Diagnostics Appoints Hcfocus To Support Commencement Of Its U.S. Market Access Program
02/04/2024 02:14
April 2 (Reuters) - Cleo Diagnostics Ltd COV.AX :
* CO APPOINTED HCFOCUS TO SUPPORT COMMENCEMENT OF ITS U.S.
MARKET
ACCESS PROGRAM
Further company coverage: COV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsAustralia's Cleo Diagnostics jumps after cancer screening test meets milestone
Brief: Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test
Australia's Cleo Diagnostics jumps as ovarian cancer test hits validation milestone
Brief: Cleo Diagnostics Receives First Batch Of Commercially Manufactured Test Kits
Brief: Cleo Diagnostics Raises A$5M